JP Morgan Chase’s Meihua International Medical Technologies MHUA Stock Holding History

JP Morgan Chase’s Portfolio MHUA Stock Details MHUA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-10	Closed	-$7K	–	7171
2023 Q1	$7K	Sell	10 -2	-17%	-$3.3K	﹤0.01%	6189
2022 Q4	$10K	Buy	+12	New	+$10.1K	﹤0.01%	6034

Other funds holding MHUA

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase's MHUA Position: Q2 2023 in Review

JP Morgan Chase sold out of Meihua International Medical Technologies (MHUA) in Q2 2023, closing a stake of 10 shares — an estimated $7K sold.

JP Morgan Chase first reported a position in MHUA in Q4 2022 and held it in 2 quarters. The position peaked at $10K in Q4 2022. 4 funds tracked by Wall St. Rank hold MHUA as of Q2 2023.

JP Morgan Chase reported no remaining Meihua International Medical Technologies position as of Q2 2023 after selling out during the quarter.
JP Morgan Chase sold 10 Meihua International Medical Technologies shares in Q2 2023, an estimated $7K.
JP Morgan Chase first reported a position in Meihua International Medical Technologies in Q4 2022 and held it in 2 quarters.
JP Morgan Chase's Meihua International Medical Technologies position peaked at $10K in Q4 2022.
4 funds tracked by Wall St. Rank held Meihua International Medical Technologies as of Q2 2023.

Based on JP Morgan Chase's 13F filing for Q2 2023, filed 11 Aug 2023.